PP19 Regulation of Energy Balance

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Obesity, Adipocyte Biology and Appetite-Basic
Saturday, April 2, 2016: 11:30 AM-11:45 AM
Room 205 (BCEC)
Susanne Ursula Miedlich, MD, University of Rochester Medical Center, Rochester, NY and To Be Determined

Nothing to Disclose: SUM Disclosure Not Provided: DHB, CMA
Erin C Hanlon, PhD1, Fanny Delebecque1 and Eve Van Cauter, PhD2, (1)University of Chicago, Chicago, IL
(2)Sleep, Metabolism and Health Center, University of Chicago, Chicago, IL
Poster Board Number: SAT 604
Sikarin Upala, M.D., Bassett Medical Center, Cooperstown, NY, Anawin Sanguankeo, M.D., Bassett Medical Center, United States, NY, Veeravich Jaruvongvanich, University of Hawaii at Honolulu, Honolulu, HI and Tanawan Riangwiwat, MD, University of Hawaii at Honolulu
Poster Board Number: SAT 603
Rajesh K Jain, MD and Tamara J Vokes, MD, Section of Endocrinology, University of Chicago, Chicago, IL
Poster Board Number: SAT 602
Ken Fujioka, MD1, Frank Lyons Greenway III, MD2, David C.W. Lau3, Patrick M. O'Neil, PhD4, Sten Madsbad5, Søren Kruse Lilleøre6, Trine Vang Skjøth, MD6 and John Wilding, DM, FRCP7, (1)Division of Endocrinology, Scripps Clinic, La Jolla, CA
(2)Clinical Trials, Pennington Biomedical Research Center, Baton Rouge, LA
(3)University of Calgary Cumming School of Medicine, Calgary, AB, Canada
(4)Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC
(5)Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark
(6)Novo Nordisk A/S, Søborg, Denmark
(7)Obesity and Endocrinology, University Hospital Aintree, Liverpool, United Kingdom
Poster Board Number: SAT 600


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire